𝛼SK or SearchIPO Databook: Shanghai Shengsheng Pharmaceutical Cold Chain Technology (HK) - Jul 2026
150 Views24 Jul 2026 10:14
SUMMARY
- Shanghai Shengsheng Pharmaceutical Cold Chain Technology is a leading integrated temperature-control supply chain service provider in China for the pharmaceutical and life science industry, with a core focus on clinical.
- Shanghai Shengsheng is the largest temperature-control supply chain service provider in China for the pharmaceutical and life science industry in 2025. Revenue increased from RMB614.2 million in 2023 to RMB727.6.
- Revenue was RMB727,574 in 2025, with a gross profit margin of 36.9% in the same year. Adjusted net profit was RMB151,984 in 2025.
This content is AI-generated and displayed for general informational purposes only. Please verify independently before use.
Begin exploring Smartkarma's AI-augmented investing intelligence platform with a complimentary Preview Pass to:
- Unlock research summaries
- Follow top, independent analysts
- Receive personalised alerts
- Access Analytics, Events and more
Join 55,000+ investors, including top global asset managers overseeing $13+ trillion.
Upgrade later to our paid plans for full-access.
or
Already have an account? Sign In Now
Discussions
(Paid Plans Only)
Price Chart(Sign Up to Access)
- IPO Databook: Shanghai Shengsheng Pharmaceutical Cold Chain Technology (HK) - Jul 202624 Jul 2026
x